This test is most useful if any of these apply to you.
Whether you are running a ketogenic experiment, managing diabetes, fasting to test your metabolic flexibility, or trying to understand an unexplained metabolic shift, you want to know one thing: is my body actually burning fat for fuel right now? 3-HB (3-hydroxybutyric acid) is the molecule that answers that question. When your liver runs low on glucose, it converts fat into 3-HB and ships it out through your bloodstream, with a portion filtered into urine.
Here is the catch with the cheap ketone strips at the drugstore: they do not actually detect 3-HB. They react with a different ketone called acetoacetate, and the correlation between the two is poor at higher ketone levels. This test directly quantifies 3-HB in urine, which gives you a more honest picture of how deeply your metabolism has shifted toward fat-derived fuel.
3-HB belongs to a family of three molecules called ketone bodies, made primarily in your liver from fatty acids when blood sugar is low. The liver releases them into your blood, and tissues like your brain, heart, and muscles can use them as an alternative to glucose for energy. A small fraction is filtered out by your kidneys and leaves in urine, which is what this test captures.
Of the three ketone bodies, 3-HB is usually the most abundant in blood during sustained ketosis, often outnumbering acetoacetate by several fold. That is why measuring 3-HB directly tends to give a truer read on the depth of ketosis than the older dipstick chemistry, which mostly sees acetoacetate.
If you have type 1 diabetes (a condition where your pancreas makes little or no insulin), rising 3-HB is the chemical signature of impending ketoacidosis, a medical emergency where ketones build up faster than your body can clear them. In a randomized trial of 123 young people with type 1 diabetes, those who used direct blood 3-HB monitoring during illness days had a lower rate of hospital and emergency visits compared to those using urine ketone strips.
That trial measured blood 3-HB rather than urine 3-HB, so the size of the benefit does not transfer directly to this test. The takeaway is that quantitative 3-HB measurement caught dangerous ketosis earlier than dipstick urine ketones did. When 3-HB rises substantially in blood, metabolic acidosis can develop, and at higher concentrations severe symptoms like rapid deep breathing appear. Anyone with diabetes who sees an unexpectedly elevated urinary 3-HB should pair it with a blood ketone meter check and contact their care team that day.
Higher fasting ketone bodies may also signal trouble brewing long before diabetes is diagnosed. In a prospective study of about 3,307 adults from the general population, higher fasting ketone bodies (including 3-HB) predicted future type 2 diabetes, with the association holding up after adjustment for traditional risk factors. That study measured ketones in plasma, not urine, so urinary 3-HB has not been directly validated for this purpose. Still, it is a useful framing: persistently elevated baseline ketones in someone who is not fasting or doing keto can be an early signal of disordered insulin signaling.
Pregnancy is a state of natural metabolic stress, and ketone production rises to feed both mother and fetus. In a study of second trimester maternal biofluids, urinary 3-HB was elevated in pregnancies complicated by fetal malformations, reflecting enhanced ketone production and altered energy metabolism. In gestational diabetes (a temporary form of diabetes during pregnancy), higher plasma 3-HB tracks with worse glucose tolerance and disturbed lipid metabolism. An unexpectedly high reading during pregnancy is worth investigating, particularly alongside a glucose tolerance test.
In rare inherited conditions called organic acidemias (propionic and methylmalonic acidemia are the best known), urinary 3-HB is one of the markers used to monitor whether the body is heading into acute metabolic decompensation. In a deep metabolic phenotyping study of patients with these disorders, urinary 3-HB and other ketones rose during acute decompensation even when the classic diagnostic markers did not change. For most readers without a diagnosed metabolic disease, this context is less directly relevant, but it illustrates how sensitive urinary 3-HB is to real-time shifts in cellular energy balance.
Several cancers show altered ketone metabolism, though the picture is more complex than a simple high-is-bad story. A systematic review and meta-analysis of urinary metabolomics found 3-HB consistently elevated in the urine of colorectal cancer cases compared to controls. In relapsed or refractory diffuse large B-cell lymphoma (a type of blood cancer), baseline serum 3-HB above a defined threshold was strongly associated with worse progression-free and overall survival, independent of traditional risk scores. Higher plasma 3-HB has also been associated with increased pulmonary nodule risk in a study of nearly 2,000 adults.
Counterintuitively, a Mendelian randomization study (which uses genetic variants to estimate causal effects) found that genetically higher circulating 3-HB was associated with lower risk of several cancers, including liver cancer and lymphoma. The likely explanation is that 3-HB is a phenotype indicator, not a single good-or-bad signal. Your baseline ketone production reflects the health of your liver, your insulin signaling, and your metabolic flexibility, which protect against cancer. But in someone who already has cancer, tumors can drive up ketone use and supply, producing higher readings. This is one reason a single elevated 3-HB result outside the context of fasting or a ketogenic diet warrants further metabolic workup rather than alarm in isolation.
Urinary 3-HB is a research and exploratory marker, not a standardized clinical test with universally agreed cutpoints. That makes serial measurement more useful than any single reading. Your number can swing widely with what you ate last night, how hydrated you are, whether you exercised that morning, and the time of day.
Get a baseline under consistent conditions, ideally first morning urine after a typical day. If you are testing whether a ketogenic diet, fasting protocol, or new medication is genuinely shifting your metabolism, retest in two to four weeks. If you are tracking metabolic health more broadly, retest every three to six months. The trend matters more than any single value, especially given how much normal day-to-day variation exists with this marker.
If your result is high and you have been fasting, on a ketogenic diet, or taking an SGLT2 inhibitor medication, the finding is expected and confirms the metabolic state you would predict. Pair it with a glucose check to make sure you are in nutritional ketosis rather than ketoacidosis.
If your result is high and you have none of those exposures, the next step is to investigate the underlying metabolic state. Check fasting glucose, HbA1c, fasting insulin, and consider an oral glucose tolerance test. In someone with known diabetes, an unexpectedly high reading should prompt a same-day blood ketone meter check and contact with your care team to rule out ketoacidosis. Persistent elevation without an obvious dietary or medication explanation may warrant evaluation by an endocrinologist, particularly if combined with weight loss, abdominal pain, or breathing changes.
If your result is low and you are intentionally pursuing ketosis through diet or fasting, it is a signal your protocol is not producing the metabolic shift you intended. The most common culprits are hidden carbohydrates, inadequate fat intake, or simply not enough time on the protocol to deplete liver glycogen stores. Adjust and retest in two to four weeks.
Evidence-backed interventions that affect your 3-Hydroxybutyric Acid level
3-Hydroxybutyric Acid is best interpreted alongside these tests.
3-Hydroxybutyric Acid is included in these pre-built panels.